 Home > Medical News > Latest Medical News > Astellas geritinib fumarate tablets reach the primary endpoint of overall survival

Astellas geritinib fumarate tablets reach the primary endpoint of overall survival

 Last Update: 2021-04-24
 Source: Internet
 Author: User

Tags

stage 2 leukemia

adverse reaction melatonin

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Astellas Pharmaceuticals Group (TSE: 4503, President and CEO: Dr.

The COMMODORE trial is a multicenter open randomized controlled study conducted in China and other countries to compare the efficacy of geritinib treatment and salvage chemotherapy in adult patients with relapsed or refractory FLT3 mutant AML.

Earlier this year, the China National Medical Products Administration (NMPA) conditionally approved geritinib for the treatment of FMS-like tyrosine kinase 3 (FLT3) mutations detected by fully validated detection methods Adult patients with relapsed or refractory acute myeloid leukemia (AML).

Astellas plans to submit COMMODORE's test results to the China National Medical Products Administration for regular approval for marketing.

Acute myeloid leukemia is a tumor that affects the blood and bone marrow, and its incidence increases with age.

In an earlier trial, 319 patients with relapsed or refractory acute myeloid leukemia (with FLT3 mutation) who received at least one dose of 120 mg/day of geritinib were evaluated for the safety of geritinib.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.